3-Cyclopropylmethyl-6,11-dimethyl-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocine-8-carboxylic acid amide

ID: ALA297428

Chembl Id: CHEMBL297428

PubChem CID: 9839245

Max Phase: Preclinical

Molecular Formula: C19H26N2O

Molecular Weight: 298.43

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Synonyms: Rac-8-Carboxamidocyclazocine | CHEMBL297428|Rac-8-Carboxamidocyclazocine|BDBM50101160|PD090880|3-Cyclopropylmethyl-6,11-dimethyl-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocine-8-carboxylic acid amide

Canonical SMILES:  CC1C2Cc3ccc(C(N)=O)cc3C1(C)CCN2CC1CC1

Standard InChI:  InChI=1S/C19H26N2O/c1-12-17-10-14-5-6-15(18(20)22)9-16(14)19(12,2)7-8-21(17)11-13-3-4-13/h5-6,9,12-13,17H,3-4,7-8,10-11H2,1-2H3,(H2,20,22)

Standard InChI Key:  FAVQVALXVLMHLE-UHFFFAOYSA-N

Alternative Forms

Associated Targets(Human)

OPRD1 Tclin Delta opioid receptor (15096 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRM1 Tclin Mu opioid receptor (19785 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRK1 Tclin Kappa opioid receptor (16155 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

OPRM1 Mu opioid receptor (3620 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRD1 G_PROTEIN_RECEP_F1_2 domain-containing protein (14 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRK1 Kappa opioid receptor (4577 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 298.43Molecular Weight (Monoisotopic): 298.2045AlogP: 2.72#Rotatable Bonds: 3
Polar Surface Area: 46.33Molecular Species: BASEHBA: 2HBD: 1
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 10.33CX LogP: 2.86CX LogD: 0.03
Aromatic Rings: 1Heavy Atoms: 22QED Weighted: 0.93Np Likeness Score: 0.72

References

1. Wentland MP, Lou R, Dehnhardt CM, Duan W, Cohen DJ, Bidlack JM..  (2001)  3-Carboxamido analogues of morphine and naltrexone. synthesis and opioid receptor binding properties.,  11  (13): [PMID:11425545] [10.1016/s0960-894x(01)00278-5]
2. Wentland MP, Lou R, Lu Q, Bu Y, VanAlstine MA, Cohen DJ, Bidlack JM..  (2009)  Syntheses and opioid receptor binding properties of carboxamido-substituted opioids.,  19  (1): [PMID:19027293] [10.1016/j.bmcl.2008.10.134]
3. Wentland MP, Jo S, Gargano JM, VanAlstine MA, Cohen DJ, Bidlack JM..  (2012)  Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 8. High affinity ligands for opioid receptors in the picomolar Ki range: oxygenated N-(2-[1,1'-biphenyl]-4-ylethyl) analogues of 8-CAC.,  22  (24): [PMID:23142613] [10.1016/j.bmcl.2012.10.081]
4. Turnaturi R, Marrazzo A, Parenti C, Pasquinucci L..  (2018)  Benzomorphan scaffold for opioid analgesics and pharmacological tools development: A comprehensive review.,  148  [PMID:29477074] [10.1016/j.ejmech.2018.02.046]

Source